Vegan omega 3 algae DHA supplement: the evidence

Vegans have significantly lower circulating DHA than omnivores, and flaxseed won't fully close that gap. The conversion rate from ALA to DHA in humans is estimated at under 5% in most studies. Algal DHA, the original marine source, is the only plant-derived option shown in randomised trials to raise erythrocyte DHA to levels comparable with fish-eaters. Here's what the primary literature actually says.

Algal DHA is not a workaround for vegans who want omega 3s. It is the original source, and the evidence for its bioavailability is solid.

From this read

What the evidence actually shows

The gap between what vegans consume and what their cells actually contain is well documented. Harris et al. (2025) analysed erythrocyte fatty acid profiles across dietary groups in the Adventist Health Study-2, one of the largest dietary cohort studies in existence. Vegans had the lowest DHA concentrations of any group, sitting meaningfully below lacto-ovo vegetarians, pesco-vegetarians, and omnivores. The gap wasn't marginal.

Neufingerl et al. (2022) conducted a systematic review of nutrient intake in plant-based eaters versus meat-eaters and found that long-chain omega-3 fatty acid intake, specifically EPA and DHA, was consistently lower in those avoiding animal products. This wasn't a surprise. What the review made clear is that ALA-rich foods, however abundant in a vegan diet, do not reliably translate to adequate DHA status in tissues.

The intervention data is where it gets more useful. García-Maldonado et al. (2023) ran a crossover randomised controlled trial in healthy adults supplementing with a novel algal DHA product. Over 8 weeks, erythrocyte DHA concentrations rose significantly. The effect was dose-dependent and the form was well tolerated. That's the kind of trial I actually find useful: real people, real blood markers, a control condition, and a crossover design that controls for individual variation.

My honest read: the evidence that vegans are low in DHA is strong. The evidence that algal DHA raises DHA status is solid. The cardiovascular implications of that gap are where the picture gets more complex, and I'll get into that below.

The biology: what DHA is actually doing in the cardiovascular system

DHA, docosahexaenoic acid, is a 22-carbon, 6-double-bond fatty acid. It's one of the most structurally demanding lipids the body uses. It concentrates in cell membranes where high fluidity matters: the brain, the retina, and the heart. In cardiomyocytes, DHA's presence in the phospholipid bilayer influences ion channel function, membrane receptor sensitivity, and the electrical properties of cardiac tissue.

From a cardiovascular standpoint, the relevant pathways involve triglyceride metabolism and platelet behaviour. DHA may reduce hepatic triglyceride synthesis by downregulating sterol regulatory element-binding protein-1c (SREBP-1c), a transcription factor that drives lipogenesis. It also competes with arachidonic acid for incorporation into platelet membranes, which may influence eicosanoid production and, by extension, platelet aggregation dynamics. The word "may" is doing real work in those sentences. These are plausible, mechanistically coherent pathways. They're not certainties.

DHA is also a precursor to specialised pro-resolving mediators (SPMs), including resolvins and protectins, which are involved in the resolution of inflammatory signalling. This is distinct from simply suppressing inflammation. The distinction matters because SPMs don't blunt the acute immune response; they help terminate it. Whether supplemental algal DHA at typical doses meaningfully shifts SPM production in humans is a question the human data hasn't fully answered yet.

What I find genuinely interesting is that fish don't synthesise DHA either. They accumulate it from the microalgae they eat. Algal DHA is therefore not a vegan approximation of the real thing. It is the real thing, one step earlier in the food chain.

Why flaxseed and chia won't solve this

I want to spend a moment on this because it's a common source of confusion. Flaxseed, chia, hemp, and walnuts are all good sources of ALA, alpha-linolenic acid. ALA is an essential omega-3 fatty acid. The body cannot synthesise it. So far, so good.

The problem is the conversion step. ALA must be elongated and desaturated through a series of enzymatic reactions to become EPA and then DHA. The enzymes involved, delta-6 desaturase and delta-5 desaturase, are the same enzymes that process omega-6 fatty acids. In a typical Western diet, omega-6 intake is high, and competition for these enzymes is fierce. The result is that ALA-to-DHA conversion is estimated at under 5% in most adults, and some studies put it considerably lower.

Bakaloudi et al. (2021) reviewed the adequacy of vegan diets across multiple nutrients and flagged long-chain omega-3 status as one of the most consistent shortfalls. The review noted that dietary ALA intake in vegans can actually be reasonable, but that this doesn't translate to adequate EPA or DHA in blood or tissue. That's the core issue.

Malhotra et al. (2025) made a similar point in their analytical review of nutritional deficiencies in vegan diets, identifying long-chain omega-3 fatty acids as a priority nutrient for supplementation, not just dietary attention.

If you're vegan and eating flaxseed every day, I'm not saying stop. ALA has its own relevance. But if your goal is to maintain circulating DHA at levels comparable to omnivores, you need a preformed source. Algae is the only one that doesn't involve fish.

Dosing: what the clinical evidence supports

The dose question is where a lot of supplement labels quietly fail. Many algal DHA products on the market deliver 200 mg per day or less. The RCT data suggests you need more than that to meaningfully shift erythrocyte DHA.

García-Maldonado et al. (2023) used doses in the 400 to 500 mg/day range in their crossover trial and saw significant increases in erythrocyte DHA over 8 weeks. The European Food Safety Authority (EFSA) has previously noted that 250 mg/day of DHA is associated with normal brain function in adults, and that cardiovascular-relevant intakes in the literature typically sit between 250 and 1000 mg/day depending on the endpoint being studied.

For athletes and active individuals, the picture may be slightly different. West et al. (2023) reviewed nutritional considerations for vegan athletes and highlighted omega-3 status as a particular concern, noting that exercise-related inflammation and recovery may be influenced by the ratio of omega-6 to omega-3 in cell membranes. The review didn't prescribe a specific dose but indicated that supplementation with preformed DHA is likely warranted for vegan athletes.

The KōJō Daily Formula includes algal DHA as a registered ingredient. The dose sits in the range supported by the RCT literature. It's there because the gap is real, not because algae sounds good on a label.

One practical note: DHA is a fat-soluble compound. Taking it with a meal that contains some dietary fat will improve absorption. This isn't a minor point. Some people take fat-soluble supplements on an empty stomach and then wonder why their blood levels don't shift.

The cardiovascular gap in vegan populations: what the cohort data says

Vegan diets have a genuinely interesting cardiovascular profile. On one hand, the observational data is broadly favourable. Dinu et al. (2018) conducted a systematic review and meta-analysis of observational studies and found that vegan diets were associated with lower total cholesterol, LDL cholesterol, and BMI compared to omnivorous diets. Marrone et al. (2021) reviewed vegan diet evidence in the context of metabolic syndrome and noted associations with improved lipid profiles and blood pressure markers.

Key et al. (2022) published long-term findings from the EPIC-Oxford study, one of the largest prospective cohort studies of diet and health in the UK. Plant-based diets were associated with lower ischaemic heart disease risk, though the picture for stroke was more nuanced, with some plant-based groups showing slightly elevated haemorrhagic stroke risk. The authors noted that this may partly relate to lower circulating cholesterol, and possibly to lower omega-3 status, though causality wasn't established.

That last point matters. A diet that looks good on several cardiovascular markers can still have specific nutrient gaps that warrant attention. DHA is one of them. I'm not framing this as a reason to avoid a vegan diet. I'm framing it as a reason to be deliberate about the nutrients a vegan diet doesn't naturally provide in adequate amounts.

Other ingredients in the cardiovascular stack: what the evidence supports and where it's thin

DHA doesn't exist in isolation in a well-designed formula. A few other ingredients appear in the cardiovascular literature, and I want to be honest about where the evidence is strong and where it's preliminary.

Aged Garlic Extract

Aged garlic extract has been studied in the context of blood pressure and arterial stiffness. Some trials show modest effects on systolic blood pressure in hypertensive populations. Research is ongoing, and large-scale RCTs in healthy populations are limited. I include it because the mechanism is plausible and the safety profile is well established, not because I'd claim it's a cardiovascular fix.

Olive Leaf Extract

Olive leaf extract contains oleuropein, which has been studied for its effects on endothelial function and blood pressure. Some small trials show effects on blood pressure markers. Research is ongoing, and large-scale human trials are limited. The Mediterranean diet literature gives this compound some indirect support, but that's not the same as a direct RCT on the extract itself.

Grape Seed Extract and Pine Bark Extract

Both contain oligomeric proanthocyanidins (OPCs). Some research suggests these may support endothelial function through nitric oxide pathways. Research is ongoing, and large-scale human trials are limited. The mechanistic rationale is coherent. The human evidence at the doses typically used in supplements is thinner than I'd like.

Ubiquinol

Ubiquinol is the reduced, active form of CoQ10. It's present in mitochondria and has been studied in the context of heart failure and statin-related myopathy. Research is ongoing, and large-scale human trials in healthy populations are limited. It's an interesting compound. The evidence base in clinical populations is more developed than in healthy adults.

I also want to mention that if you're thinking about the broader picture of nutrient gaps on a vegan diet, the relationship between vitamin D3 and K2 is worth understanding. I've written about that separately: vitamin d3 and k2 why take them together. And if stress is a factor in your health equation, which it often is for people paying attention to cardiovascular markers, the evidence on adaptogenic and nutritional interventions is worth a look: stress supplements uk what the natural evidence shows.

Who is most likely to benefit from algal DHA supplementation

Not everyone needs to supplement. But certain groups have a stronger case for it.

Vegans and strict vegetarians are the obvious candidates. The data from Harris et al. (2025) and Neufingerl et al. (2022) both point to consistently lower DHA status in these groups. If you've been vegan for several years and have never supplemented with preformed DHA, your erythrocyte DHA is very likely lower than it would be on an omnivorous diet.

Vegan athletes face an amplified version of this. West et al. (2023) specifically flagged omega-3 status as a concern for this population, where the demands on cell membrane integrity and inflammatory resolution are higher than in sedentary individuals.

Pregnant and breastfeeding vegans have a particularly strong case. DHA accumulates in foetal brain tissue during the third trimester and in breast milk during lactation. Koller et al. (2024) reviewed health outcomes in vegan children and adolescents and noted that DHA status is a consistent concern in this population, with potential implications for neurodevelopment. That's a separate article, but it's worth mentioning here.

Older adults on plant-based diets also warrant attention. Sutter et al. (2021) focused on children but the broader nutrient adequacy literature suggests that ageing reduces delta-6 desaturase activity, making ALA conversion even less efficient with age.

Frequently asked questions

My honest take

I came to algal DHA for practical reasons. I wanted a cardiovascular formula that was fully vegan-compatible without compromising on the nutrients where plant-based diets genuinely fall short. DHA was the obvious one.

What surprised me when I read the literature properly was how consistent the deficit is. It's not that vegans are doing something wrong. It's that the conversion pathway from ALA to DHA is genuinely inefficient, and that inefficiency compounds over years. The cohort data from Harris et al. (2025) made that concrete for me in a way that a mechanistic argument alone doesn't.

I'm also honest with myself about what the cardiovascular evidence does and doesn't show. The observational data on vegan diets is broadly positive. The EPIC-Oxford findings from Key et al. (2022) are genuinely encouraging on ischaemic heart disease. But the DHA gap is real, it's measurable in blood, and it's correctable with algal supplementation. That's enough for me to include it.

What I'm less certain about is the precise cardiovascular benefit of correcting DHA status in an already-healthy vegan adult. The mechanistic case is coherent. The direct RCT evidence linking algal DHA supplementation to hard cardiovascular endpoints in vegans is thinner than I'd like. I'd be overstating it to claim otherwise. What I can say is that the bioavailability data is solid, the safety profile is excellent, and the deficit it's addressing is well documented.

If you're vegan, or mostly plant-based, and you've never thought about preformed DHA, this is the one I'd start with before worrying about most other supplements.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.